FDA NDC Directory · JSON-LD · Markdown

Buprenorphine

NDC 50742-375 · HUMAN PRESCRIPTION DRUG · PATCH, EXTENDED RELEASE

Labeler / ManufacturerINGENUS PHARMACEUTICALS, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA210272
Dosage form / routePATCH, EXTENDED RELEASE · TRANSDERMAL
Active ingredientsBUPRENORPHINE (15 ug/h)
Marketing started20231101
Package count1

External sources

Source: openFDA. Public-domain (CC0).